Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System

SCOTTSDALE, Ariz., June 29, 2011 /PRNewswire/ -- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix® II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears. CrossFix® II will be on display at the 2011 American Orthopaedic Society for Sports Medicine Annual Meeting, July 7-10 in San Diego, CA.  

Tal David, MD, orthopedic sports medicine specialist, San Diego, CA, commented, "The design enhancements for CrossFix II serve to improve the integrity and strength of the meniscal repair, which I expect to have a positive impact on patient outcomes. The fast, simple and easily reproducible repair technique adds to the efficiency of the procedure in the operating room."  

The CrossFix® II platform offers a unique minimally invasive, all-suture meniscal repair that reduces the risk of chondral injury associated with other implantable meniscal devices.  Its "all-inside" technique uses suture delivery needles, available in both curved and straight designs, inserted through a single incision to gain access to multiple tear sites from the inside surface of the meniscus. The simple procedure, which can be performed in minutes using the Company's proprietary instantaneous mattress stitch and pre-tied, sliding Hot Knot™, replicates the repair of standard open suturing techniques.

The enhanced CrossFix® II now includes sharper, stiffer suture delivery needles, which have inspired a simpler technique for needle insertion into the joint space and the meniscus. CrossFix® II also features an improvement in suture strength resulting in a high strength biomechanical repair.

David Springer, CEO of Cayenne Medical, said, "Evolving our already best-in-class meniscal repair technology to further enhance performance and cater to specific surgeon needs represents Cayenne Medical's commitment to providing innovative solutions for the sports medicine market.  We fully expect CrossFix II to be as well received as our second generation soft tissue knee ligament reconstruction device, AperFix II, launched only a few months ago."

CrossFix® II is now commercially available in the U.S. The new needle insertion technique will be demonstrated at the Cayenne Medical AOSSM Booth (#815) and field training is available upon request.

About Cayenne Medical, Inc.:

Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. Cayenne Medical also currently offers products that address previously unmet clinical needs in knee ligament reconstruction, including the AperFix® II System and iFix® System.  The company was founded in 2005 and is focused on leading the transformation of traditional arthroscopic procedures, by applying advanced technology through minimally invasive techniques. For more information, visit www.cayennemedical.com.

SOURCE Cayenne Medical, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED